Companies: 10,795·Total market cap: $144.5T
RedHill Biopharma Ltd.

RedHill Biopharma Ltd.

RDHLNASDAQHealthcare● Active
$1.02
$-0.01(-0.97%)
Market Cap$3205714
P/E Ratio—
52W High$3.31
52W Low$0.71
Overview
Stock ranking:Drug Manufacturers - Specialty & Generic·Healthcare·View All Market Cap Rankings →

RedHill Biopharma Ltd. (RDHL) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · RDHL · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-4.00rdhl eps ttm · rdhl earnings per shareEarnings history
PE Ratio (TTM)—rdhl pe ratio ttm · rdhl price to earningsPE Ratio deep dive
Revenue (TTM)$9.5Mrdhl revenue ttm · rdhl annual revenueFull revenue history
Dividend YieldNo Dividenddoes rdhl pay dividends · rdhl dividend yieldDividend history
Shares Outstanding3.2Mrdhl shares outstanding · rdhl floatShares outstanding history
Next EarningsAug 13, 2026Est.rdhl earnings date · rdhl next earningsEarnings history

Explore RedHill Biopharma Ltd. Data

rdhl stock data · financials
Market Cap$3.2Mrdhl market cap · rdhl valuation
Analyst Forecast$— · Buy
DividendsNo Dividenddoes redhill biopharma ltd. pay dividends · rdhl dividend yield
Revenue$286000-96.44%redhill biopharma ltd. annual revenue · rdhl revenue
EarningsEPS $0.00+100.00%rdhl earnings · rdhl eps
PE Ratio—rdhl pe ratio · rdhl price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$286000.00▼ 96.44% YoY
202320242025
redhill biopharma ltd. revenue · rdhl revenue 2025
FY 2025Net Income-$429000.00▲ +94.81% YoY
202320242025
redhill biopharma ltd. net income · rdhl profit 2025
FY 2025EPS$0.00▲ +100.00% YoY
202320242025
rdhl eps · redhill biopharma ltd. earnings per share 2025
TTM:Revenue: $9.5MNet Income: -$9.3MEPS: $-4.00View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy10 analystsis rdhl a buy · rdhl analyst rating
Strong Buy
0
Buy
10
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$—Low
$1.02Current
$—Avg Target
$—High
rdhl price target · rdhl 12 month forecast

Total: 10 · Buy rate: 100.0%

Stock Performance

Full History
1D-0.97%
1W+2.00%
1M+0.99%
3M+10.87%
YTD-0.97%
1Y-50.24%
5Y-99.99%

About RedHill Biopharma Ltd.

CEODror Ben-Asher
IPO DateJan 7, 2013
Employees35
CountryIL
Websiteredhillbio.com

RedHill Biopharma Ltd. is a specialized pharmaceutical firm concentrating its efforts mainly on therapies for digestive tract conditions and various infections. The company markets several gastrointes…

Drug Manufacturers - Specialty & GenericHealthcareNASDAQADRIL

what is redhill biopharma ltd. · rdhl stock overview · redhill biopharma ltd. company profile · who is redhill biopharma ltd. ceo · rdhl NASDAQ · redhill biopharma ltd. headquarters · redhill biopharma ltd. business segments

About Stock Overview & Key Data

RedHill Biopharma Ltd. (RDHL) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Jan 7, 2013. As of the latest trading session, RDHL stock price is $1.02, with a market capitalization of $3.2M. The stock has returned -50.24% over the past 12 months and -0.97% year-to-date.

According to 10 Wall Street analysts, the consensus rating for RedHill Biopharma Ltd. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, RedHill Biopharma Ltd. reported revenue of $286000.00 and net income of -$429000.00. For detailed data — including RedHill Biopharma Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, RedHill Biopharma Ltd. (RDHL) stock price is $1.02. The stock is traded on NASDAQ under the ticker symbol RDHL. The 52-week range is $0.71 – $3.31.

RDHL stock priceRDHL quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice